...
首页> 外文期刊>Folia histochemica et cytobiologica >The immunoreactivity of TGF-beta 1 in non-alcoholic fatty liver disease
【24h】

The immunoreactivity of TGF-beta 1 in non-alcoholic fatty liver disease

机译:TGF-β1在非酒精性脂肪肝病中的免疫反应性

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction. Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease which becomes a rapidly growing health problem in the Western countries. The development of the disease is most often connected to obesity. NAFLD is also considered as the hepatic manifestation of metabolic syndrome. Transforming growth factor beta 1 (TGF-beta 1) plays an important role in the pathogenesis of liver fibrosis, being involved in activation of hepatic stellate cells, stimulation of collagen gene transcription, and suppression of matrix metalloproteinase expression. The objective of the study was to evaluate by immunohistochemistry the expression of TGF-beta 1 in the liver tissue of NAFLD patients and correlate it with anthropometric, biochemical and routine histological parameters.
机译:介绍。 非酒精性脂肪肝病(NAFLD)是一种常见的慢性肝病,成为西方国家的迅速增长的健康问题。 这种疾病的发展最常与肥胖相连。 NAFLD也被认为是代谢综合征的肝脏表现。 转化生长因子β1(TGF-β1)在肝纤维化的发病机制中起重要作用,参与激活肝星状细胞,胶原基因转录的刺激,以及基质金属蛋白酶的抑制。 该研究的目的是通过免疫组织化学评估TGF-Beta1在NAFLD患者的肝组织中的表达,并与人类测量,生化和常规组织学参数相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号